The DigiGlasses Project is working on a project called DIGIGLASSES, funded by the EU. This development aims to help people with low vision in everyday life. We have started a survey to identify the needs of people with low vision, please help us by completing the survey.
The homepage with more info is: digiglasses.eu
Survey for experts: http://survey.mfkk.eu/index.php?sid=32136&lang=en
Survey for people with low vision: http://survey.mfkk.eu/index.php?sid=29995&lang=en
Thank you in advance!
Nano Retina, a joint venture of Zyvex Labs (www.zyvexlabs.com),
and Rainbow Medical (www.rainbowmedical.co.il), is developing
Bio-Retina, a bionic retina designed to restore sight to those
suffering from retinal degenerative diseases. Bio-Retina incorporates
various nano-size components in one tiny, flat implant,
approximating the size of a child’s fingernail bed. Its simple 30-
minute implant procedure requires local anesthesia, a small incision
and “gluing” of the device to the damaged retina. Return of sight is
anticipated to be instantaneous: 24×24 with the first generation and
72×72 with the second generation product (see illustrative pictures
below), enabling persons who have undergone the procedure to
watch TV and identify faces. Recovery time is estimated at up to
Nano Retina Inc.
8 Mascit Street, POB 4100,
Herzeliya Pituach, 46140,
For more info: www.nano-retina.com
Macular Degeneration Association
Living with Macular Degeneration
Age- Related Macular Degeneration Educational Program
With co-presenter: Doctors Vision Center
You are invited to join Program Chair, Peter Hollis, O.D.(Medical Director Doctor’s Vision Center) and Retina Specialists Carey Pate, M.D. and Nitin Gupta, M.D., to learn about the latest advances in research, medications and treatments which have the potential to improve quality of life for those with macular degeneration. Meet the doctors and get answers to your questions from nationally recognized macular experts. Learn what you can do to keep your eyesight.
Saturday, September 22, 2012
9:00 AM – 3:00 PM
McKimmon Conference and Training Center
1101 Gorman Street
Raleigh, NC 27606
Seating is limited. Registration is required.
For information and to register please call (941) 870-4399
Event attendees will learn the latest treatment advances evolving in the macular field, including the revolutionary Macula Risk® test, a genetic test predicting one’s likelihood of developing AMD. In addition to establishing an individual’s genetic predisposition to macular degeneration, the test is also useful in formulating a customized treatment plan for those already diagnosed with AMD. This test is covered by Medicare and most major insurance companies.
For more info: http://www.maculardegenerationassociation.org